Be heard this November: The Cancer Promise



The effort against cancer is not only waged in America’s research labs and clinics but also through public policy decisions made by elected officials. This is why the Colorectal Cancer Alliance includes advocacy as a key part of its mission.
The upcoming November election will likely have a major impact on cancer research, screening, and clinical care. While the Alliance does not endorse any political candidate, we encourage all candidates to support policies that align with our mission to end colorectal cancer in our lifetime.
As part of our advocacy efforts, the Colorectal Cancer Alliance is promoting The Cancer Promise, an initiative created by the American Cancer Society. Political candidates are asked to take a pledge to advance important cancer-related policies. Specifically, the pledge includes the following commitments:
This initiative helps raise awareness about cancer and health care, both of which often receive too little attention in today’s contentious election cycle. Additionally, it informs voters that a candidate is committed to advancing cancer research, screening, and quality care.
Here is a list of presidential, Senate, and House candidates, along with those who have signed the promise to date. We encourage you to review the status and email candidates in your state or district, urging them to sign. This request should be sent to Republicans and Democrats alike. Ending cancer is not a partisan issue—cancer research and care are critical to all Americans.

hrough Project Cure CRC, the Alliance is fueling bold, early-stage research with the potential to transform colorectal cancer treatment. Dr. Lisa Mielke’s groundbreaking work explores how the gut’s immune system and nerve signaling influence cancer growth—opening the door to new therapeutic approaches, including repurposed existing drugs. This is what’s possible when promising ideas get the support they need to move forward.

Americans increasingly view colorectal cancer screening encouragement as an act of love, with new survey data showing rising openness about lifesaving prevention.

Biomarker testing can guide colorectal cancer treatment and improve outcomes. Learn how CLEAR for CRC is helping patients access this critical tool.